| Literature DB >> 21671829 |
Kye-Hyung Kim1, Seunghwan Lee, Shinwon Lee, Na Ra Yun, Nam Joong Kim, Kyung-Sang Yu, In-Jin Jang, Wan Beom Park, Myoung-Don Oh.
Abstract
Voriconazole is the drug of choice for invasive aspergillosis. We describe three patients who presented with severe hyponatremia after the initiation of voriconazole treatment. One patient expired while the other two patients recovered after a dose adjustment or discontinuation of the antifungal. The voriconazole trough levels were checked in all and two were elevated. These findings mandate monitoring electrolyte levels during voriconazole therapy.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21671829 DOI: 10.3109/13693786.2011.587210
Source DB: PubMed Journal: Med Mycol ISSN: 1369-3786 Impact factor: 4.076